STOCK TITAN

State Street Corporation (NYSE: STT) discloses 5.3% holding in Myriad Genetics

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

State Street Corporation reported beneficial ownership of common stock of Myriad Genetics, Inc.. State Street disclosed beneficial ownership of 4,985,060 shares of common stock, representing 5.3% of the class.

All voting and dispositive authority is held on a shared basis through asset management subsidiaries, with 4,866,068 shares having shared voting power and 4,985,060 shares having shared dispositive power, and no sole voting or dispositive power reported.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 4,985,060 shares Common stock of Myriad Genetics beneficially owned by State Street Corporation
Percent of class 5.3% Percentage of Myriad Genetics common stock class held by State Street Corporation
Shared voting power 4,866,068 shares Shares of Myriad Genetics with shared power to vote or direct the vote
Shared dispositive power 4,985,060 shares Shares of Myriad Genetics with shared power to dispose or direct disposition
Sole voting power 0 shares Shares of Myriad Genetics with sole power to vote
Sole dispositive power 0 shares Shares of Myriad Genetics with sole power to dispose
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 4985060.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting power financial
"Shared power to vote or to direct the vote: 4,866,068"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared power to dispose or to direct the disposition of: 4,985,060"
parent holding company financial
"If a parent holding company has filed this schedule, pursuant to (ii)(G)"
Investment Company Act of 1940 regulatory
"an investment company registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Myriad Genetics (MYGN) shares does State Street Corporation report owning?

State Street Corporation reports beneficial ownership of 5.3% of Myriad Genetics’ common stock, corresponding to 4,985,060 shares. This level of ownership triggers the requirement to file a Schedule 13G as a significant institutional shareholder.

How many Myriad Genetics (MYGN) shares does State Street Corporation beneficially own?

State Street Corporation reports beneficial ownership of 4,985,060 shares of Myriad Genetics common stock. This position represents 5.3% of the class and is held through various State Street Global Advisors asset management subsidiaries.

Does State Street Corporation have sole or shared voting power over its MYGN shares?

State Street reports 0 shares with sole voting power and 4,866,068 shares with shared voting power. Voting authority is exercised collectively through its asset management affiliates rather than solely by the parent company.

What dispositive power does State Street Corporation report over Myriad Genetics (MYGN) shares?

State Street reports 0 shares with sole dispositive power and 4,985,060 shares with shared dispositive power. This means decisions to sell or otherwise dispose of these shares are made on a shared basis by its listed subsidiaries.

Which subsidiaries of State Street are involved in holding Myriad Genetics (MYGN) shares?

The filing identifies SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, and State Street Global Advisors Trust Company as investment adviser subsidiaries associated with the reported MYGN holdings.





62855J104

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



STATE STREET CORPORATION
Signature:ELIZABETH SCHAEFER
Name/Title:SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
Date:08/07/2026